Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein wntless homolog (WLS) is an integral membrane protein responsible for mediating the secretion and sorting of Wnt ligands, a family of secreted, lipid-modified signaling proteins essential for cell communication, embryonic development, and tissue homeostasis[1][3][4][5]. WLS binds Wnt proteins within the endoplasmic reticulum and facilitates their trafficking through the secretory pathway to the cell surface, enabling Wnt ligands to reach and activate their target receptors on neighboring cells[1][2][3][4]. WLS is evolutionarily conserved and indispensable for canonical and non-canonical Wnt signaling, with loss-of-function mutations implicated in developmental disorders, including Zaki syndrome[2][3][5]. While not a classical receptor, enzyme, or transporter, WLS is a critical node in the Wnt signaling pathway, making it a potential target for modulating Wnt-driven diseases—though no approved drugs directly target WLS at present.
Drugs (if developed) would likely inhibit or modulate WLS to disrupt Wnt ligand secretion, thereby modulating Wnt pathway signaling implicated in development and disease
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein wntless homolog (WLS).